|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL1A1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL1A2 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL3A1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL4A1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL5A1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL6A1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of ELN mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of FN1 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of MMP14 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of MMP2 mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of PDGFB mRNA]; Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of TGFB1 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Y 27632 results in increased expression of ABCC2 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO EXP |
Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein]; Y 27632 inhibits the reaction [Soot results in increased expression of ACTA2 mRNA]; Y 27632 inhibits the reaction [Soot results in increased expression of ACTA2 protein] Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 mRNA]; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 protein]; Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of ACTA2 mRNA]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of ACTA2 protein] Y 27632 results in decreased expression of ACTA2 mRNA |
CTD |
PMID:11035001 PMID:13678700 PMID:23517783 PMID:32860865 PMID:33792148 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases activity increases expression |
ISO |
Y 27632 results in increased activity of AKT1 protein Y 27632 results in increased expression of AKT1 mRNA |
CTD |
PMID:17322126 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
ISO |
Y 27632 results in decreased expression of ALCAM mRNA |
CTD |
PMID:35388712 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions affects cleavage increases secretion |
ISO EXP |
ROCK1 protein affects the reaction [Y 27632 affects the cleavage of APP protein] Y 27632 inhibits the reaction [aluminum maltolate results in decreased expression of and results in decreased secretion of APP protein modified form] Y 27632 results in increased secretion of APP protein modified form |
CTD |
PMID:14615541 PMID:19741129 PMID:20395307 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgef17 |
Rho guanine nucleotide exchange factor 17 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein] |
CTD |
PMID:23195829 |
|
NCBI chr 1:155,230,607...155,290,163
Ensembl chr 1:155,233,168...155,290,498
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
Y 27632 results in increased expression of ATP1B2 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] |
CTD |
PMID:25305180 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression multiple interactions |
ISO |
Y 27632 results in decreased expression of BAD mRNA Y 27632 inhibits the reaction [Cisplatin results in increased expression of BAD mRNA] |
CTD |
PMID:20878077 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO |
Y 27632 inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] Y 27632 results in increased expression of BCL2 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bik |
BCL2-interacting killer |
multiple interactions decreases expression |
ISO |
Y 27632 inhibits the reaction [Cisplatin results in increased expression of BIK mRNA] Y 27632 results in decreased expression of BIK mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Asbestos, Crocidolite results in increased secretion of CASP1 protein modified form]; Y 27632 inhibits the reaction [Nanotubes, Carbon results in increased secretion of CASP1 protein modified form] |
CTD |
PMID:24760326 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP3 protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein] Y 27632 inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein] |
CTD |
PMID:22564901 PMID:25305180 PMID:28743511 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [TNF protein results in increased cleavage of CASP8 protein] |
CTD |
PMID:28743511 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP9 protein] |
CTD |
PMID:22564901 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Soot results in increased expression of CCL2 protein] |
CTD |
PMID:33792148 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of CCL4 mRNA] |
CTD |
PMID:29033935 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [lysophosphatidic acid results in increased expression of CCN2 protein] |
CTD |
PMID:15200425 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression multiple interactions |
ISO |
Y 27632 results in decreased expression of CCNA2 protein Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of CCNA2 protein] |
CTD |
PMID:32417439 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
EXP |
Y 27632 promotes the reaction [EGF protein results in increased expression of CCND1 protein] Y 27632 results in increased expression of CCND1 mRNA |
CTD |
PMID:16799973 PMID:20578043 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression multiple interactions |
ISO |
Y 27632 results in decreased expression of CCND3 protein Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of CCND3 protein] |
CTD |
PMID:32417439 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cd14 |
CD14 molecule |
increases expression multiple interactions |
ISO |
Y 27632 results in increased expression of CD14 protein Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of CD14 protein] |
CTD |
PMID:32417439 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of CD86 mRNA] |
CTD |
PMID:29033935 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdh1 |
cadherin 1 |
decreases activity multiple interactions |
ISO EXP |
Y 27632 results in decreased activity of CDH1 protein Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of CDH1 mRNA]; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of CDH1 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein] |
CTD |
PMID:16030252 PMID:32860865 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
EXP |
Y 27632 results in decreased expression of CDK4 mRNA |
CTD |
PMID:20578043 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression multiple interactions |
ISO |
Y 27632 results in decreased expression of CDKN1A mRNA Y 27632 inhibits the reaction [Cisplatin results in increased expression of CDKN1A mRNA] |
CTD |
PMID:20878077 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
EXP |
Y 27632 results in increased expression of CDKN1B mRNA |
CTD |
PMID:20578043 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cfl1 |
cofilin 1 |
decreases phosphorylation decreases expression |
EXP ISO |
Y 27632 results in decreased phosphorylation of CFL1 protein Y 27632 results in decreased expression of CFL1 protein modified form |
CTD |
PMID:17138966 PMID:20610540 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
Y 27632 results in increased activity of and results in increased phosphorylation of CHUK protein |
CTD |
PMID:17322126 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
affects localization |
ISO |
Y 27632 affects the localization of COL17A1 protein |
CTD |
PMID:14691950 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL1A1 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA] |
CTD |
PMID:21439370 PMID:23517783 PMID:30682444 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA] Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL1A2 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA] |
CTD |
PMID:21439370 PMID:23517783 PMID:30682444 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL3A1 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL4A1 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL5A1 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL6A1 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Asbestos, Crocidolite results in increased secretion of CTSB protein modified form]; Y 27632 inhibits the reaction [Nanotubes, Carbon results in increased secretion of CTSB protein modified form] |
CTD |
PMID:24760326 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:11751986 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Dst |
dystonin |
affects localization |
ISO |
Y 27632 affects the localization of DST protein |
CTD |
PMID:14691950 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Phenylephrine results in increased expression of EDN1 mRNA] |
CTD |
PMID:11739382 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
Y 27632 promotes the reaction [EGF protein results in increased expression of CCND1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eln |
elastin |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of ELN mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Eng |
endoglin |
decreases expression |
ISO |
Y 27632 results in decreased expression of ENG mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
ISO |
Y 27632 results in increased expression of ERCC1 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
increases expression |
ISO |
Y 27632 results in increased expression of XPD mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
increases expression |
ISO |
Y 27632 results in increased expression of ERCC5 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ezr |
ezrin |
increases phosphorylation |
EXP |
Y 27632 deficiency results in increased phosphorylation of EZR protein |
CTD |
PMID:14732730 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions decreases activity |
ISO |
Y 27632 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein] [Y 27632 results in decreased activity of ROCK1 protein] which results in decreased activity of F2 protein |
CTD |
PMID:15284075 PMID:16675616 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Y 27632 results in increased expression of FABP4 mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Cisplatin results in increased expression of FAS mRNA] |
CTD |
PMID:20878077 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
decreases expression multiple interactions |
ISO |
Y 27632 results in decreased expression of FASLG mRNA Y 27632 inhibits the reaction [Cisplatin results in increased expression of FASLG mRNA] |
CTD |
PMID:20878077 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP ISO |
Y 27632 inhibits the reaction [Glucose results in increased expression of FN1 protein] Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of FN1 mRNA] |
CTD |
PMID:23376009 PMID:30682444 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein] |
CTD |
PMID:11739382 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Y 27632 promotes the reaction [cobaltous chloride affects the localization of HIF1A protein] |
CTD |
PMID:16772336 PMID:30831131 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO EXP |
Y 27632 inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] Y 27632 inhibits the reaction [Glucose results in increased expression of ICAM1 protein] |
CTD |
PMID:22226621 PMID:23376009 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Y 27632 promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:12799187 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]]; Y 27632 inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]] |
CTD |
PMID:15705589 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Asbestos, Crocidolite results in increased expression of and results in increased secretion of IL1B protein]; Y 27632 inhibits the reaction [Nanotubes, Carbon results in increased expression of and results in increased secretion of IL1B protein]; Y 27632 promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] Y 27632 inhibits the reaction [Soot results in increased expression of IL1B protein] |
CTD |
PMID:12799187 PMID:24760326 PMID:33792148 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of IL6 mRNA]; Y 27632 inhibits the reaction [Soot results in increased expression of IL6 protein]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of IL6 protein] |
CTD |
PMID:17729120 PMID:29033935 PMID:33792148 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itga3 |
integrin subunit alpha 3 |
multiple interactions |
ISO |
Y 27632 affects the localization of [ITGA3 protein binds to ITGB1 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itga6 |
integrin subunit alpha 6 |
multiple interactions |
ISO |
Y 27632 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression multiple interactions |
ISO |
Y 27632 results in increased expression of ITGAM protein Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein] |
CTD |
PMID:32417439 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions |
ISO |
Y 27632 affects the localization of [ITGA3 protein binds to ITGB1 protein] |
CTD |
PMID:14691950 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb4 |
integrin subunit beta 4 |
multiple interactions |
ISO |
Y 27632 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Kirrel1 |
kirre like nephrin family adhesion molecule 1 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of KIRREL1 mRNA] |
CTD |
PMID:18367845 |
|
NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299
|
|
G |
Lama3 |
laminin subunit alpha 3 |
affects localization |
ISO |
Y 27632 affects the localization of LAMA3 protein |
CTD |
PMID:14691950 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Limk1 |
LIM domain kinase 1 |
decreases expression |
ISO |
Y 27632 results in decreased expression of LIMK1 protein modified form |
CTD |
PMID:17138966 |
|
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP ISO |
Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11739382 PMID:22226621 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:22226621 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:11739382 PMID:22226621 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [methylmercuric chloride results in decreased expression of MAPT protein] |
CTD |
PMID:20869980 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mbp |
myelin basic protein |
increases expression |
EXP |
Y 27632 results in increased expression of MBP mRNA |
CTD |
PMID:20578043 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions decreases expression |
ISO |
Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein] Y 27632 results in decreased expression of MKI67 protein |
CTD |
PMID:32417439 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of MMP14 mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions |
ISO |
[Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP2 protein Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of MMP2 mRNA] |
CTD |
PMID:19896475 PMID:30682444 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
Y 27632 inhibits the reaction [4-cresol results in increased expression of MMP9 protein]; Y 27632 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] [Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP9 protein |
CTD |
PMID:15728660 PMID:19896475 PMID:30910523 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msn |
moesin |
increases phosphorylation multiple interactions |
EXP |
Y 27632 deficiency results in increased phosphorylation of MSN protein Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MSN protein] |
CTD |
PMID:14732730 PMID:30783172 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
[Everolimus co-treated with Y 27632] inhibits the reaction [4-cresol results in increased phosphorylation of MTOR protein]; Y 27632 inhibits the reaction [4-cresol results in increased phosphorylation of MTOR protein] |
CTD |
PMID:30910523 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myh2 |
myosin heavy chain 2 |
affects localization |
ISO |
Y 27632 affects the localization of MYH2 protein |
CTD |
PMID:16030252 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA] |
CTD |
PMID:11739382 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myl7 |
myosin light chain 7 |
multiple interactions decreases phosphorylation |
ISO |
Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein] Y 27632 results in decreased phosphorylation of MYL7 protein |
CTD |
PMID:15621049 |
|
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions decreases phosphorylation |
ISO EXP |
Y 27632 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein]; Y 27632 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein]; Y 27632 inhibits the reaction [TNF protein results in increased phosphorylation of MYL9 protein] Y 27632 results in decreased phosphorylation of MYL9 protein Y 27632 inhibits the reaction [[Escin affects the susceptibility to Calcium] which results in increased phosphorylation of MYL9 protein]; Y 27632 inhibits the reaction [[Escin affects the susceptibility to Guanosine 5'-O-(3-Thiotriphosphate)] which results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:11751986 PMID:12745062 PMID:15034928 PMID:15284075 PMID:29660437 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [arsenic trioxide results in increased phosphorylation of and affects the localization of NCF1 protein] |
CTD |
PMID:18424721 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
affects localization |
ISO |
Y 27632 affects the localization of NFKB1 protein |
CTD |
PMID:17322126 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO EXP |
Y 27632 results in decreased expression of and results in increased phosphorylation of NFKBIA protein Y 27632 inhibits the reaction [Glucose results in decreased expression of NFKBIA protein] Y 27632 inhibits the reaction [Soot results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17322126 PMID:23376009 PMID:33792148 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Y 27632 promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of NOS2 mRNA]; Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of NOS2 protein]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of NOS2 mRNA] Y 27632 inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]] |
CTD |
PMID:12799187 PMID:15705589 PMID:17729120 PMID:29033935 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases phosphorylation |
ISO |
Mevalonic Acid inhibits the reaction [Y 27632 results in increased phosphorylation of NOS3 protein] |
CTD |
PMID:17322126 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 mRNA] |
CTD |
PMID:18367845 |
|
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [lysophosphatidic acid results in increased expression of NPPA protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] |
CTD |
PMID:11739382 PMID:25449040 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
decreases expression |
ISO |
Y 27632 results in decreased expression of NR4A3 mRNA |
CTD |
PMID:16005304 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
Y 27632 results in decreased expression of PARP1 protein |
CTD |
PMID:24676941 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression decreases expression |
ISO |
Mevalonic Acid inhibits the reaction [Y 27632 results in increased expression of PCNA protein]; Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of PCNA protein] Y 27632 results in decreased expression of PCNA protein |
CTD |
PMID:17322126 PMID:32417439 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of PDGFB mRNA] |
CTD |
PMID:30682444 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA] |
CTD |
PMID:30783172 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pkn2 |
protein kinase N2 |
decreases activity |
ISO |
Y 27632 results in decreased activity of PKN2 protein |
CTD |
PMID:10998351 |
|
NCBI chr 2:231,793,584...231,898,953
Ensembl chr 2:231,793,584...231,898,953
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression |
EXP ISO |
Y 27632 results in increased expression of PPARG mRNA |
CTD |
PMID:20578043 PMID:35388712 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions |
ISO EXP |
Y 27632 inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of PPP1R12A protein] Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein] |
CTD |
PMID:18367845 PMID:25305180 PMID:25449040 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein] |
CTD |
PMID:23195829 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Rac1 |
Rac family small GTPase 1 |
increases activity |
EXP |
Y 27632 results in increased activity of RAC1 protein |
CTD |
PMID:12105187 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions decreases expression |
ISO |
Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of RB1 protein modified form] Y 27632 results in decreased expression of RB1 protein modified form |
CTD |
PMID:32417439 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rdx |
radixin |
decreases phosphorylation |
EXP |
Y 27632 results in decreased phosphorylation of RDX protein |
CTD |
PMID:14732730 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization decreases expression |
ISO EXP |
Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] Y 27632 inhibits the reaction [Glucose affects the localization of RELA protein] Y 27632 affects the localization of RELA protein Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide affects the localization of RELA protein]; Y 27632 inhibits the reaction [Soot results in increased phosphorylation of RELA protein] Y 27632 results in decreased expression of RELA mRNA |
CTD |
PMID:17322126 PMID:22226621 PMID:23376009 PMID:29033935 PMID:33792148 PMID:35388712 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression multiple interactions |
ISO |
[Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP2 protein; [Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP9 protein; Y 27632 results in decreased expression of RHOA protein [Everolimus co-treated with Y 27632] inhibits the reaction [4-cresol results in increased expression of RHOA protein]; Y 27632 inhibits the reaction [4-cresol results in increased expression of RHOA protein] |
CTD |
PMID:19896475 PMID:30910523 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases activity multiple interactions |
ISO |
[Y 27632 results in decreased activity of ROCK1 protein] which results in decreased activity of F2 protein ROCK1 protein affects the reaction [Y 27632 affects the cleavage of APP protein] |
CTD |
PMID:14615541 PMID:16675616 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
decreases activity multiple interactions |
EXP |
Y 27632 results in decreased activity of ROCK2 protein Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of ROCK2 mRNA] |
CTD |
PMID:10998351 PMID:30783172 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
decreases activity |
ISO |
Y 27632 results in decreased activity of RPS6KA3 protein |
CTD |
PMID:10998351 |
|
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
decreases activity |
ISO |
Y 27632 results in decreased activity of RPS6KA5 protein |
CTD |
PMID:10998351 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Rs1 |
retinoschisin 1 |
increases secretion |
ISO |
Y 27632 results in increased secretion of RS1 protein |
CTD |
PMID:21738583 |
|
NCBI chr X:33,962,440...33,992,203
Ensembl chr X:33,963,657...33,992,115
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
decreases expression |
ISO |
Y 27632 results in decreased expression of RUNX2 mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Scn7a |
sodium voltage-gated channel alpha subunit 7 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of SCN7A mRNA] |
CTD |
PMID:13678700 |
|
NCBI chr 3:51,335,841...51,438,308
Ensembl chr 3:51,335,841...51,438,256
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
increases expression |
ISO |
Y 27632 results in increased expression of SLC12A2 protein |
CTD |
PMID:21474433 |
|
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
decreases expression |
ISO |
Y 27632 results in decreased expression of SLC31A1 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
decreases expression |
ISO |
Y 27632 results in decreased expression of SLPI mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Sox10 |
SRY-box transcription factor 10 |
increases expression |
EXP |
Y 27632 results in increased expression of SOX10 mRNA |
CTD |
PMID:20578043 |
|
NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:110,725,274...110,735,544
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP |
Y 27632 inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein] |
CTD |
PMID:22031849 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Tagln |
transgelin |
decreases expression |
EXP |
Y 27632 results in decreased expression of TAGLN mRNA |
CTD |
PMID:11035001 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; Y 27632 inhibits the reaction [Glucose results in increased expression of TGFB1 protein] Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of TGFB1 mRNA] Y 27632 inhibits the reaction [Soot results in increased expression of TGFB1 protein] |
CTD |
PMID:13678700 PMID:23376009 PMID:30682444 PMID:33792148 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
[cobaltous chloride co-treated with Y 27632] results in increased expression of TH protein |
CTD |
PMID:16772336 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
decreases expression |
ISO |
Y 27632 results in decreased expression of THY1 mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Tlr4 |
toll-like receptor 4 |
decreases expression |
ISO |
Y 27632 results in decreased expression of TLR4 mRNA |
CTD |
PMID:35388712 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases activity |
ISO |
Y 27632 inhibits the reaction [TNF protein affects the localization of and results in increased cleavage of VIM protein]; Y 27632 inhibits the reaction [TNF protein affects the localization of VIM protein modified form]; Y 27632 inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]; Y 27632 inhibits the reaction [TNF protein results in increased cleavage of CASP8 protein]; Y 27632 inhibits the reaction [TNF protein results in increased phosphorylation of MYL9 protein]; Y 27632 promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of TNF mRNA]; Y 27632 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of TNF protein]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of IL6 protein]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of NOS2 mRNA] Y 27632 results in decreased activity of TNF protein |
CTD |
PMID:12799187 PMID:15034928 PMID:17560598 PMID:17729120 PMID:28743511 PMID:29033935 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
Y 27632 results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
affects response to substance multiple interactions decreases expression increases expression |
ISO |
TP53 protein affects the susceptibility to Y 27632 TP53 protein promotes the reaction [Y 27632 results in decreased susceptibility to Cisplatin]; Y 27632 inhibits the reaction [Cisplatin results in increased expression of TP53 mRNA] Y 27632 results in decreased expression of TP53 mRNA Y 27632 results in increased expression of TP53 protein |
CTD |
PMID:11839765 PMID:20878077 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein] |
CTD |
PMID:30831131 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [Oxygen deficiency results in increased expression of TRPC6 protein] |
CTD |
PMID:30831131 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
Y 27632 inhibits the reaction [TNF protein affects the localization of and results in increased cleavage of VIM protein]; Y 27632 inhibits the reaction [TNF protein affects the localization of VIM protein modified form] Y 27632 inhibits the reaction [Soot results in increased expression of VIM mRNA]; Y 27632 inhibits the reaction [Soot results in increased expression of VIM protein] |
CTD |
PMID:28743511 PMID:33792148 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xpa |
XPA, DNA damage recognition and repair factor |
increases expression |
ISO |
Y 27632 results in increased expression of XPA mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
increases expression |
ISO |
Y 27632 results in increased expression of XPC mRNA |
CTD |
PMID:20878077 |
|
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
|
|